Product Program year 2025 Source: CMS Open Payments

Aurlumyn

Drug Vasodilators

NDC 50633-340-01

Open in the dashboard

General payments

$50,953

81 payments

Research payments

$0

0 payments

Through program year 2025, $50,953 in general payments and $0 in research payments were reported against Aurlumyn (Vasodilators).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2025 General $50,953 81

Breakdown

Who paid General payments · program year 2025
  1. BTG International, Inc. $50,953 81 payments
Top recipients General payments · program year 2025
  1. Denver Health Medical Center Teaching hospital · CO $27,386 54% · 8 payments
  2. Ken Zafren Emergency Medicine · Stanford, CA $9,000 18% · 3 payments
  3. Bruce Friedman Critical Care Medicine · Augusta, GA $6,783 13% · 3 payments
  4. Fariborz Rezai Critical Care Medicine · Livingston, NJ $900 2% · 1 payment
  5. Jennifer Dow Emergency Medicine · Anchorage, AK $878 2% · 4 payments

The top 5 of 60 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Emergency Medicine $13,896 59% · 16 practitioners
  2. Critical Care Medicine Internal Medicine $7,683 33% · 2 practitioners
  3. Trauma Surgery Surgery $696 3% · 2 practitioners
  4. Surgery $214 <1% · 8 practitioners
  5. Hematology & Oncology Internal Medicine $169 <1% · 1 practitioner

The top 5 of 18 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Colorado $27,562 54% · 7 recipients
  2. Alaska $9,956 20% · 3 recipients
  3. Georgia $6,866 13% · 2 recipients
  4. Massachusetts $1,350 3% · 2 recipients
  5. New Jersey $1,051 2% · 2 recipients

The top 5 of 24 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

81 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record